TICRO’s animal models facilitate the evaluation of candidate therapeutics, vaccines and adjuvants for toxic side effects leading to impaired immune cell function and impaired immunity to infections. We offer murine models of infection using a broad range of pathogens, with a focus on respiratory infections, including: Influenza A and B viruses, Mycobacterium tuberculosis, Pseudomonas aeruginosa, Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae, Yersinia enterocolitica, Yersinia pestis, Listeria monocytogenes, Campylobacter jejunii, and Francisella tularensis (strain LVS).
For more information, please contact:
William Reiley, Ph.D.
Senior CRO Program Manager
(518) 891-3080, ext. 315